BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19918177)

  • 1. Host-pathogen interplay of Haemophilus ducreyi.
    Janowicz DM; Li W; Bauer ME
    Curr Opin Infect Dis; 2010 Feb; 23(1):64-9. PubMed ID: 19918177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of the Skin Pathogen
    Brothwell JA; Griesenauer B; Chen L; Spinola SM
    Front Immunol; 2020; 11():615402. PubMed ID: 33613541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Haemophilus ducreyi LspA1 protein inhibits phagocytosis by using a new mechanism involving activation of C-terminal Src kinase.
    Dodd DA; Worth RG; Rosen MK; Grinstein S; van Oers NS; Hansen EJ
    mBio; 2014 May; 5(3):e01178-14. PubMed ID: 24902122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutropenia restores virulence to an attenuated Cu,Zn superoxide dismutase-deficient Haemophilus ducreyi strain in the swine model of chancroid.
    San Mateo LR; Toffer KL; Orndorff PE; Kawula TH
    Infect Immun; 1999 Oct; 67(10):5345-51. PubMed ID: 10496915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining Potential Vaccine Targets of Haemophilus ducreyi Trimeric Autotransporter Adhesin DsrA.
    Fusco WG; Choudhary NR; Stewart SM; Alam SM; Sempowski GD; Elkins C; Leduc I
    Monoclon Antib Immunodiagn Immunother; 2015 Apr; 34(2):73-82. PubMed ID: 25897604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Haemophilus ducreyi serum resistance antigen DsrA confers attachment to human keratinocytes.
    Cole LE; Kawula TH; Toffer KL; Elkins C
    Infect Immun; 2002 Nov; 70(11):6158-65. PubMed ID: 12379693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A humoral immune response confers protection against Haemophilus ducreyi infection.
    Cole LE; Toffer KL; Fulcher RA; San Mateo LR; Orndorff PE; Kawula TH
    Infect Immun; 2003 Dec; 71(12):6971-7. PubMed ID: 14638786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialylation of lipooligosaccharides is dispensable for the virulence of Haemophilus ducreyi in humans.
    Spinola SM; Li W; Fortney KR; Janowicz DM; Zwickl B; Katz BP; Munson RS
    Infect Immun; 2012 Feb; 80(2):679-87. PubMed ID: 22144477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of an Interaction Network between an Extracellular Bacterial Pathogen and the Human Host.
    Griesenauer B; Tran TM; Fortney KR; Janowicz DM; Johnson P; Gao H; Barnes S; Wilson LS; Liu Y; Spinola SM
    mBio; 2019 Jun; 10(3):. PubMed ID: 31213562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Swine model of Haemophilus ducreyi infection.
    Hobbs MM; San Mateo LR; Orndorff PE; Almond G; Kawula TH
    Infect Immun; 1995 Aug; 63(8):3094-100. PubMed ID: 7622236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chancroid and Haemophilus ducreyi: an update.
    Trees DL; Morse SA
    Clin Microbiol Rev; 1995 Jul; 8(3):357-75. PubMed ID: 7553570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulated immune profiles for skin and dendritic cells are associated with increased host susceptibility to Haemophilus ducreyi infection in human volunteers.
    Humphreys TL; Li L; Li X; Janowicz DM; Fortney KR; Zhao Q; Li W; McClintick J; Katz BP; Wilkes DS; Edenberg HJ; Spinola SM
    Infect Immun; 2007 Dec; 75(12):5686-97. PubMed ID: 17893130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemophilus ducreyi Hfq contributes to virulence gene regulation as cells enter stationary phase.
    Gangaiah D; Labandeira-Rey M; Zhang X; Fortney KR; Ellinger S; Zwickl B; Baker B; Liu Y; Janowicz DM; Katz BP; Brautigam CA; Munson RS; Hansen EJ; Spinola SM
    mBio; 2014 Feb; 5(1):e01081-13. PubMed ID: 24520065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Haemophilus ducreyi collagen binding outer membrane protein NcaA is required for virulence in swine and human challenge models of chancroid.
    Fulcher RA; Cole LE; Janowicz DM; Toffer KL; Fortney KR; Katz BP; Orndorff PE; Spinola SM; Kawula TH
    Infect Immun; 2006 May; 74(5):2651-8. PubMed ID: 16622201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemophilus ducreyi inhibits phagocytosis by U-937 cells, a human macrophage-like cell line.
    Wood GE; Dutro SM; Totten PA
    Infect Immun; 2001 Aug; 69(8):4726-33. PubMed ID: 11447144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outer membrane protein P4 is not required for virulence in the human challenge model of Haemophilus ducreyi infection.
    Janowicz DM; Zwickl BW; Fortney KR; Katz BP; Bauer ME
    BMC Microbiol; 2014 Jun; 14():166. PubMed ID: 24961160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chancroid and Haemophilus ducreyi.
    Morse SA
    Clin Microbiol Rev; 1989 Apr; 2(2):137-57. PubMed ID: 2650859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of mtrC in Haemophilus ducreyi increases sensitivity to human antimicrobial peptides and activates the CpxRA regulon.
    Rinker SD; Trombley MP; Gu X; Fortney KR; Bauer ME
    Infect Immun; 2011 Jun; 79(6):2324-34. PubMed ID: 21444663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemophilus ducreyi SapA contributes to cathelicidin resistance and virulence in humans.
    Mount KL; Townsend CA; Rinker SD; Gu X; Fortney KR; Zwickl BW; Janowicz DM; Spinola SM; Katz BP; Bauer ME
    Infect Immun; 2010 Mar; 78(3):1176-84. PubMed ID: 20086092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemophilus ducreyi: from sexually transmitted infection to skin ulcer pathogen.
    Lewis DA; Mitjà O
    Curr Opin Infect Dis; 2016 Feb; 29(1):52-7. PubMed ID: 26658654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.